中国医疗美容
中國醫療美容
중국의료미용
China Medical Cosmetology
2014年
2期
99-99,102
,共2页
李荣兴%温裕庆%雷根娥%钟毅
李榮興%溫裕慶%雷根娥%鐘毅
리영흥%온유경%뢰근아%종의
心得安%婴幼儿血管瘤%应用价值
心得安%嬰幼兒血管瘤%應用價值
심득안%영유인혈관류%응용개치
propranolol%infantile hemangiomas%application value
目的:探讨心得安于婴幼儿血管瘤治疗中的应用价值与安全性。方法:选取血管瘤患儿83例,第1天每次0.5mg/kg(体重),第2天,每次0.75mg/kg(体重),第2天及以后,每次1.0mg/kg(体重),每日早晚8点各1次。观察和比较治疗前后血管瘤的颜色、大小、相关指标、PSV、RI。结果:不同性别、不同发生部位间疗效分布差异无统计学意义(P>0.05);浅表型优良率69.77%优于深部型15.79%、混合型52.38%,治疗持续8个月患者PSV、RI分别为(23.0±5.2)cm/s、(0.85±0.11)优于治疗前(68.3±12.3)cm/s、(0.53±0.14),差异具有统计学意义(P<0.05);未见严重不良反应。结论:心得安治疗婴幼儿血管瘤疗效显著,安全可靠,但疗效受血管瘤类型影响。
目的:探討心得安于嬰幼兒血管瘤治療中的應用價值與安全性。方法:選取血管瘤患兒83例,第1天每次0.5mg/kg(體重),第2天,每次0.75mg/kg(體重),第2天及以後,每次1.0mg/kg(體重),每日早晚8點各1次。觀察和比較治療前後血管瘤的顏色、大小、相關指標、PSV、RI。結果:不同性彆、不同髮生部位間療效分佈差異無統計學意義(P>0.05);淺錶型優良率69.77%優于深部型15.79%、混閤型52.38%,治療持續8箇月患者PSV、RI分彆為(23.0±5.2)cm/s、(0.85±0.11)優于治療前(68.3±12.3)cm/s、(0.53±0.14),差異具有統計學意義(P<0.05);未見嚴重不良反應。結論:心得安治療嬰幼兒血管瘤療效顯著,安全可靠,但療效受血管瘤類型影響。
목적:탐토심득안우영유인혈관류치료중적응용개치여안전성。방법:선취혈관류환인83례,제1천매차0.5mg/kg(체중),제2천,매차0.75mg/kg(체중),제2천급이후,매차1.0mg/kg(체중),매일조만8점각1차。관찰화비교치료전후혈관류적안색、대소、상관지표、PSV、RI。결과:불동성별、불동발생부위간료효분포차이무통계학의의(P>0.05);천표형우량솔69.77%우우심부형15.79%、혼합형52.38%,치료지속8개월환자PSV、RI분별위(23.0±5.2)cm/s、(0.85±0.11)우우치료전(68.3±12.3)cm/s、(0.53±0.14),차이구유통계학의의(P<0.05);미견엄중불량반응。결론:심득안치료영유인혈관류료효현저,안전가고,단료효수혈관류류형영향。
Objective:To investigate the application value and safety experience of infantile hemangioma treatment with propranolol. Methods:Selecting 83 children with hemangiomas, 0.5mg/kg(weight) the first day, 0.75mg/kg(weight) the second day, and 1.0mg/kg(weight) every time after the second day with 1 time 8:00 in the morning and afternoon. The color, size, related indicators, PSV and RI of hemangioma were observed and compared. Results:There no statistically significant effect of sex distribution differences among different parts (P>0.05); superficial good rate is 69.77%, which is better than 15.79% of deep type, 52.38% of mixed type. PSV and RI of patients treated for 8 months are(23.0 ± 5.2) cm / s and (0.85 ± 0.11), which are better than (68.3±12.3)cm/s,(0.53±0.14)cm/s before treatment. The difference was statistically significant (P<0.05), with no severe adverse reactions. Conclusion:Propranolol treatment of infantile hemangioma has significant effect, with safe and reliable, but the effects are influenced by the type of hemangioma.